Literature DB >> 3311140

Characterisation of ocular melanoma with cutaneous melanoma antibodies.

J Bomanji1, A Garner, J Prasad, D M Albert, J L Hungerford, M Granowska, K E Britton.   

Abstract

It can be difficult to distinguish between various forms of pale intraocular tumour, and in particular between an amelanotic malignant melanoma, a choroidal haemangioma, and a solitary metastasis. If a monoclonal antibody specific for melanoma could be identified, it might be radiolabelled to provide a scanning technique which could distinguish between an ocular melanoma and a similar lesion. This pilot, in vitro study was undertaken to determine if monoclonal antibody against cutaneous melanoma recognises any antigenic similarity in ocular melanomas. Three cutaneous melanoma MoAbs 225.28S, 376.96S, and 763-24T and a non-specific MoAb HMFG2 were studied. Cell impressions were obtained from fresh ocular malignant melanomas. Standard staining techniques with immunofluorescence were used. MoAb 225.28S, 376.96S, and 763.24T were positive in melanomas with a dominant epithelioid cell type and in those with a dominant spindle cell type. It is concluded that MoAb 225.28S, 376.96S, and 763.24T may be suitable for imaging ocular melanomas after labelling with 123I, 111In, or 99mTc.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311140      PMCID: PMC1041267          DOI: 10.1136/bjo.71.9.647

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

1.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

2.  Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.

Authors:  P A Farrands; A C Perkins; M V Pimm; M J Embleton; J D Hardy; R W Baldwin; J D Hardcastle
Journal:  Lancet       Date:  1982-08-21       Impact factor: 79.321

3.  Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.

Authors:  R C Seeger; H M Rosenblatt; K Imai; S Ferrone
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

4.  Diagnostic modalities in choroidal melanoma.

Authors:  D H Char; R D Stone; A R Irvine; J B Crawford; G F Hilton; L I Lonn; A Schwartz
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

5.  Errors in the diagnosis of malignant melanoma of the choroid.

Authors:  D M Robertson; R J Campbell
Journal:  Am J Ophthalmol       Date:  1979-03       Impact factor: 5.258

6.  Molecular heterogeneity and shedding of a high-molecular-mass melanoma-associated antigen identified with monoclonal antibodies.

Authors:  A K Ng; P Giacomini; R Kantor; S Ferrone
Journal:  Clin Chem       Date:  1982-12       Impact factor: 8.327

7.  Immunochemical characterization of a human high molecular weight--melanoma associated antigen identified with monoclonal antibodies.

Authors:  B S Wilson; G Ruberto; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

10.  Radioimmunodetection of melanoma: preliminary results of a prospective study.

Authors:  G Buraggi; A Turrin; N Cascinelli; A Attili; M Gasparini; L Callegaro; S Ferrone; E Seregni; E Bombardieri; F Belli
Journal:  Int J Biol Markers       Date:  1986 Jan-Apr       Impact factor: 3.248

View more
  13 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  Ocular melanoma.

Authors:  A B Tullo; C L Dodd; J L Noble; S Owens; H Rao
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

3.  Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?

Authors:  K U Loeffler; P Bräutigam; J C Simon; S R Althauser; C Wuttig; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

4.  Imaging posterior uveal melanomas.

Authors:  I Rennie
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

5.  Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results.

Authors:  D F Schaling; J P van der Pol; M J Jager; M J van Kroonenburgh; J A Oosterhuis; D J Ruiter
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638

6.  Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma.

Authors:  D F Schaling; M J van Kroonenburgh; R A Borsje; J A Camps; H M Kakebeeke-Kemme; J A Oosterhuis; E K Pauwels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

7.  Possibilities and limitations of radioimmunoscintigraphy and conventional diagnostic modalities in choroidal melanoma.

Authors:  D F Schaling; J A Oosterhuis; M J Jager; H Kakebeeke-Kemme; E K Pauwels
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

8.  Immunoimaging of choroidal melanoma: assessment of its diagnostic accuracy and limitations in 101 cases.

Authors:  J Scheidler; G Leinsinger; C M Kirsch; O F Scheiffarth; F H Stefani; K G Riedel
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

9.  123I metaiodobenzylguanidine (MIBG) scintigraphy of retinoblastoma: preliminary experience.

Authors:  J Bomanji; J L Hungerford; J E Kingston; D A Levison; K E Britton
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

10.  Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Eur J Nucl Med       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.